1. Home
  2. ELEV vs MASK Comparison

ELEV vs MASK Comparison

Compare ELEV & MASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • MASK
  • Stock Information
  • Founded
  • ELEV 2019
  • MASK 2017
  • Country
  • ELEV United States
  • MASK China
  • Employees
  • ELEV N/A
  • MASK N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • MASK
  • Sector
  • ELEV Health Care
  • MASK
  • Exchange
  • ELEV Nasdaq
  • MASK NYSE
  • Market Cap
  • ELEV 37.6M
  • MASK 31.7M
  • IPO Year
  • ELEV 2021
  • MASK 2025
  • Fundamental
  • Price
  • ELEV $0.28
  • MASK $3.79
  • Analyst Decision
  • ELEV Buy
  • MASK
  • Analyst Count
  • ELEV 6
  • MASK 0
  • Target Price
  • ELEV $7.20
  • MASK N/A
  • AVG Volume (30 Days)
  • ELEV 852.8K
  • MASK 33.0K
  • Earning Date
  • ELEV 03-06-2025
  • MASK 01-01-0001
  • Dividend Yield
  • ELEV N/A
  • MASK N/A
  • EPS Growth
  • ELEV N/A
  • MASK 55.43
  • EPS
  • ELEV N/A
  • MASK 0.15
  • Revenue
  • ELEV N/A
  • MASK $4,561,963.00
  • Revenue This Year
  • ELEV N/A
  • MASK N/A
  • Revenue Next Year
  • ELEV N/A
  • MASK N/A
  • P/E Ratio
  • ELEV N/A
  • MASK $20.80
  • Revenue Growth
  • ELEV N/A
  • MASK 172.95
  • 52 Week Low
  • ELEV $0.42
  • MASK $2.50
  • 52 Week High
  • ELEV $5.83
  • MASK $3.99
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 22.43
  • MASK N/A
  • Support Level
  • ELEV $0.46
  • MASK N/A
  • Resistance Level
  • ELEV $0.55
  • MASK N/A
  • Average True Range (ATR)
  • ELEV 0.05
  • MASK 0.00
  • MACD
  • ELEV -0.01
  • MASK 0.00
  • Stochastic Oscillator
  • ELEV 11.97
  • MASK 0.00

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

About MASK 3 E NETWORK TECHNOLOGY GROUP LTD

3 E Network Technology Group Ltd is a business-to-business ("B2B") information technology ("IT") business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.

Share on Social Networks: